Parallel Advisors, LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$444
-15.9%
280.0%0.00%
Q2 2023$528
+40.4%
28
-71.4%
0.00%
Q1 2023$37698
+164.9%
0.00%
Q4 2021$0
-100.0%
37
-92.6%
0.00%
Q4 2018$2,000
-60.0%
5020.0%0.00%
-100.0%
Q3 2018$5,000
+25.0%
5020.0%0.00%0.0%
Q2 2018$4,0005020.00%
Other shareholders
IMMUNOGEN INC shareholders Q1 2022
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders